https://www.europesays.com/uk/260615/ Gene Key to MS Immune Regulation Discovered #AutoimmuneDiseases #BrainResearch #Egr1 #Genetics #Health #Inflammation #MultipleSclerosis #neurobiology #Neurology #Neuroscience #Research #UK #UnitedKingdom
https://www.europesays.com/uk/260615/ Gene Key to MS Immune Regulation Discovered #AutoimmuneDiseases #BrainResearch #Egr1 #Genetics #Health #Inflammation #MultipleSclerosis #neurobiology #Neurology #Neuroscience #Research #UK #UnitedKingdom
https://www.europesays.com/us/59857/ Gene Key to MS Immune Regulation Discovered #AutoimmuneDiseases #BrainResearch #Egr1 #Genetics #inflammation #MultipleSclerosis #neurobiology #Neurology #Neuroscience #research #Science #UnitedStates #UnitedStates #US
How does the heat impact your MS? Let us know in the comments below.
damn summer is hard
Vielleicht eine hilfreiche App für Menschen mit #MultipleSklerose
Stadtspaziergänge ohne #Hitze-Stress: Diese App navigiert dich durch den Schatten | t3n https://t3n.de/news/stadtspaziergaenge-ohne-hitze-stress-app-navigiert-dich-durch-den-schatten-1638540 #heat #MS #MultipleSclerosis
#Introduction Hashtags, so I can pin this post and take them out of my profile:
#Education #Research #Phd, #BCS #Computing #Teacher #CCT
#CSEd #Programming #BCS
#ActuallyAutistic
#ActuallyADHD
I live with #MultipleSclerosis
#Zen / #Nonduality #Buddhist, weirdly into #Jung
#Research topics:
- #EdAI / #AIEd - #LLMs in #Education
- #CriticalStudies of #EdTech
- #Neurodiversity in #Education, and the experience of ND educators.
Interesting thing I’ve found: people take you seriously when you call it multiple sclerosis, but handwave you when you call it MS.
Maybe not knowing the acronym and not wanting to appear not to know? We all know how society incentivises bluffing, over just asking the question like a grownup.
Vitamin D kann Krankheitsaktivität bei Multipler Sklerose senken https://deutsch.medscape.com/artikelansicht/4915095 #MS #MultipleSclerosis #MultipleSklerose
Is your brain running out of power? Scientists uncover why MS slowly breaks our motor control — and how to fight back. #MultipleSclerosis #Neuroscience #MedicalBreakthrough
https://geekoo.news/your-balance-depends-on-this-tiny-cells-power-supply/
Mind in the mist: the interplay between fatigue, information processing and brain fog
https://www.tandfonline.com/doi/full/10.1080/21641846.2025.2513194
Image is from the latest Science for ME weekly update
@mecfs
#MyalgicEncephalomyelitis #ChronicFatigueSyndrome #MEcfs #CFS #PwME @longcovid
#LongCovid #PASC #PwLC #postcovid #postcovid19 #LC #Covidlonghaulers #PostCovidSyndrome #longhaulers #COVIDBrain #NeuroPASC
#brainfog #MultipleSclerosis @multiplesclerosis
“Rest recharges my energy”; experiences and perceptions of rest in adults with long-term conditions and fatigue in rehabilitation: a qualitative study
https://www.tandfonline.com/doi/full/10.1080/09638288.2025.2512587
"Lived-experience participants noted physical symptoms, while HCPs highlighted “all-or-nothing” thinking as a significant barrier."
#longcovid @longcovid #fatigue #chronicfatigue #fibromyalgia @fibromyalgia #multiplesclerosis @multiplesclerosis #arthritis #Sjogren #Sjögrens
Can brain volume measurements forecast the course of multiple sclerosis?
Assessing the role of volumetric brain information in multiple sclerosis progression. Computational and Structural Biotechnology Journal, DOI: https://doi.org/10.1016/j.csbj.2025.05.003
CSBJ: https://www.csbj.org/
Activation of Kir4.1 Channels by 2‐D08 Promotes Myelin Repair in Multiple Sclerosis
A Multicenter, Open-label, Long-term, Safety, Tolerability, and Efficacy Study of XEN1101 in Subjects Diagnosed With Epilepsy (X-TOLE4)
https://euclinicaltrials.eu/search-for-clinical-trials/?lang=en&EUCT=2022-502282-24-00
An Exploratory, Multicenter, Randomized, double-blind, placebo-controlled study evaluating the effect and safety of pitolisant in children and adolescents with Autism Spectrum Disorders.
https://euclinicaltrials.eu/search-for-clinical-trials/?lang=en&EUCT=2023-503678-18-00
A Phase 2 Safety, Tolerability, and Proof-of-Concept Study of VGL101 in Patients With Adult-Onset Leukoencephalopathy With Axonal Spheroids and Pigmented Glia (ALSP)
https://euclinicaltrials.eu/search-for-clinical-trials/?lang=en&EUCT=2022-502505-15-00
A Randomized, Double-blind, Placebo-Controlled, Multicenter, Phase 3 Study to Evaluate the Safety, Tolerability, and Efficacy of XEN1101 as Adjunctive Therapy in Primary Generalized Tonic-Clonic Seizures (X-ACKT)
https://euclinicaltrials.eu/search-for-clinical-trials/?lang=en&EUCT=2022-502286-16-00
A Phase 2, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy, Safety, Tolerability, Pharmacodynamics, and Pharmacokinetics of BIA 28-6156 in Subjects With Parkinson’s Disease With a Pathogenic Variant in the Glucocerebrosidase (GBA1) Gene
https://euclinicaltrials.eu/search-for-clinical-trials/?lang=en&EUCT=2022-501783-18-00
A Randomized, Double-blind, Placebo-Controlled, Multicenter Phase 3 Study to Evaluate the Safety, Tolerability, and Efficacy of XEN1101 as Adjunctive Therapy in Focal-Onset Seizures
https://euclinicaltrials.eu/search-for-clinical-trials/?lang=en&EUCT=2022-502000-73-00